These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14968413

  • 21. Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies.
    Bewtra C, Xie Q, Soundararajan S, Gatalica Z, Hatcher L.
    Acta Cytol; 2005; 49(2):127-31. PubMed ID: 15839614
    [Abstract] [Full Text] [Related]

  • 22. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation.
    Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G.
    Obstet Gynecol; 2003 Mar; 101(3):481-9. PubMed ID: 12636951
    [Abstract] [Full Text] [Related]

  • 23. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.
    Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE.
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1341-9. PubMed ID: 19423515
    [Abstract] [Full Text] [Related]

  • 24. Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance.
    Kiatpongsan S, Niruthisard S, Mutirangura A, Trivijitsilp P, Vasuratna A, Chaithongwongwatthana S, Lertkhachonsuk R.
    Int J Gynecol Cancer; 2006 May; 16(1):262-5. PubMed ID: 16445642
    [Abstract] [Full Text] [Related]

  • 25. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
    Carozzi F, Bisanzi S, Sani C, Zappa M, Cecchini S, Ciatto S, Confortini M.
    J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
    [Abstract] [Full Text] [Related]

  • 26. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 27. Human papillomavirus testing in women with mild cytologic atypia.
    Bergeron C, Jeannel D, Poveda J, Cassonnet P, Orth G.
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):821-7. PubMed ID: 10831974
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
    Castle PE, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Wacholder S, Burk RD, Manos MM, Schussler JE, Macomber P, Schiffman M.
    J Clin Microbiol; 2003 Sep; 41(9):4022-30. PubMed ID: 12958220
    [Abstract] [Full Text] [Related]

  • 30. Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia.
    Lie AK, Skjeldestad FE, Hagen B, Johannessen E, Skarsvåg S, Haugen OA.
    APMIS; 1997 Feb; 105(2):115-20. PubMed ID: 9113073
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
    Söderlund-Strand A, Rymark P, Andersson P, Dillner J, Dillner L.
    J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD, Dawlett M, Wang JP, Jack A, Gong Y, Staerkel G, Guo M.
    Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
    [Abstract] [Full Text] [Related]

  • 35. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C, Batmaz G, Dane B, Cetin A.
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [Abstract] [Full Text] [Related]

  • 36. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [Abstract] [Full Text] [Related]

  • 37. Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa.
    McDonald AC, Denny L, Wang C, Tsai WY, Wright TC, Kuhn L.
    PLoS One; 2012 Jul; 7(9):e44332. PubMed ID: 22970201
    [Abstract] [Full Text] [Related]

  • 38.
    Uhlig K, Earley A, Lamont J, Dahabreh IJ, Avendano EE, Cowan JM, Feldman S.
    ; 2013 02 16. PubMed ID: 25855849
    [Abstract] [Full Text] [Related]

  • 39. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
    Hesselink AT, Bulkmans NW, Berkhof J, Lorincz AT, Meijer CJ, Snijders PJ.
    J Clin Microbiol; 2006 Oct 16; 44(10):3680-5. PubMed ID: 17021097
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.